Early-onset, conjugal, twin-discordant, and clusters of sporadic ALS: Pathway to discovery of etiology via lifetime exposome research

The identity and role of environmental factors in the etiology of sporadic amyotrophic lateral sclerosis (sALS) is poorly understood outside of three former high-incidence foci of Western Pacific ALS and a hotspot of sALS in the French Alps. In both instances, there is a strong association with exposure to DNA-damaging (genotoxic) chemicals years or decades prior to clinical onset of motor neuron disease. In light of this recent understanding, we discuss published geographic clusters of ALS, conjugal cases, single-affected twins, and young-onset cases in relation to their demographic, geographic and environmental associations but also whether, in theory, there was the possibility of exposure to genotoxic chemicals of natural or synthetic origin. Special opportunities to test for such exposures in sALS exist in southeast France, northwest Italy, Finland, the U.S. East North Central States, and in the U.S. Air Force and Space Force. Given the degree and timing of exposure to an environmental trigger of ALS may be related to the age at which the disease is expressed, research should focus on the lifetime exposome (from conception to clinical onset) of young sALS cases. Multidisciplinary research of this type may lead to the identification of ALS causation, mechanism, and primary prevention, as well as to early detection of impending ALS and pre-clinical treatment to slow development of this fatal neurological disease.

[1]  G. Kisby,et al.  MGMT, a risk factor for both genetic and environmental forms of dementia , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  P. Preux,et al.  Spatio-temporal clustering of amyotrophic lateral sclerosis in France: A population-based study , 2022, European Journal of Epidemiology.

[3]  G. Román,et al.  Amyotrophic lateral sclerosis from genotoxins alone? , 2022, The Lancet Neurology.

[4]  K. Lunetta,et al.  Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[5]  T. Bird,et al.  Progress in Amyotrophic Lateral Sclerosis Gene Discovery , 2022, Neurology: Genetics.

[6]  N. T. Dhruv,et al.  A focus on the neural exposome , 2022, Neuron.

[7]  Stephen A. Goutman,et al.  Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis , 2022, The Lancet Neurology.

[8]  T. Hansen,et al.  High incidence of amyotrophic lateral sclerosis in the Faroe Islands 2010–2020 , 2022, Annals of clinical and translational neurology.

[9]  A. Andrew,et al.  Airborne lead and polychlorinated biphenyls (PCBs) are associated with amyotrophic lateral sclerosis (ALS) risk in the U.S. , 2022, The Science of the total environment.

[10]  A. Andrew,et al.  A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk , 2022, Journal of Neurology.

[11]  A. Chiò,et al.  Unraveling the complex interplay between genes, environment, and climate in ALS , 2021, EBioMedicine.

[12]  G. Kisby,et al.  Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease , 2021, Frontiers in Neuroscience.

[13]  R. Halden,et al.  Systematic and state-of the science review of the role of environmental factors in Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease. , 2021, The Science of the total environment.

[14]  W. Camu,et al.  Reversible sub-acute motor neuron syndrome after mushroom intoxication masquerading as amyotrophic lateral sclerosis , 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[15]  M. Hasegawa,et al.  An immigrant family with Kii amyotrophic lateral sclerosis/parkinsonism–dementia complex , 2021, Neurological Sciences.

[16]  G. Kisby,et al.  Mechanisms Underlying Long-Latency Neurodegenerative Diseases of Environmental Origin , 2021, Handbook of Neurotoxicity.

[17]  G. Kisby,et al.  Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease. , 2021, Chemical research in toxicology.

[18]  A. Doyle,et al.  Occupational risk of organophosphates and other chemical and radiative exposure in the aircraft cabin: A systematic review. , 2021, The Science of the total environment.

[19]  W. Camu,et al.  An amyotrophic lateral sclerosis hot spot in the French Alps associated with genotoxic fungi , 2021, Journal of the Neurological Sciences.

[20]  H. Purohit,et al.  Myco-remediation of Chlorinated Pesticides: Insights Into Fungal Metabolic System , 2021, Indian Journal of Microbiology.

[21]  P. Spencer,et al.  Direct and Indirect Neurotoxic Potential of Metal/Metalloids in Plants and Fungi Used for Food, Dietary Supplements, and Herbal Medicine , 2021, Toxics.

[22]  R. Vermeulen,et al.  Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the Netherlands , 2021, Neurology.

[23]  K. Reddy Amyotrophic Lateral Sclerosis (Als) Disease Clusters in the United States and International Sites: Association With Glacial Lakes and Clay Minerals , 2020 .

[24]  A. Miller,et al.  Studies in Gyromitra I: the Gyromitra gigas species complex , 2020, Mycological Progress.

[25]  T. Albertson,et al.  The Toxicity, Pathophysiology, and Treatment of Acute Hydrazine Propellant Exposure: A Systematic Review. , 2020, Military medicine.

[26]  G. Kisby,et al.  Western Pacific ALS-PDC: Evidence implicating cycad genotoxins , 2020, Journal of the Neurological Sciences.

[27]  T. Hansen,et al.  Amyotrophic lateral sclerosis in the Faroe Islands – a genealogical study , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[28]  W. Reid Hypothesis: Mycotoxins Causing Amyotrophic Lateral Sclerosis , 2020 .

[29]  J. Vernoux,et al.  Warning on False or True Morels and Button Mushrooms with Potential Toxicity Linked to Hydrazinic Toxins: An Update , 2020, Toxins.

[30]  P. Spencer Etiology of Retinal and Cerebellar Pathology in Western Pacific Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex , 2020, Eye and brain.

[31]  E. Beghi,et al.  Increased risk and early onset of ALS in professional players from Italian Soccer Teams , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[32]  M. Vinceti,et al.  Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study , 2020, International journal of environmental research and public health.

[33]  Nuno Empadinhas,et al.  Microbial BMAA and the Pathway for Parkinson’s Disease Neurodegeneration , 2020, Frontiers in Aging Neuroscience.

[34]  B. Traynor,et al.  The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia , 2020, Frontiers in Neuroscience.

[35]  A. El Harfi,et al.  Classifications, properties, recent synthesis and applications of azo dyes , 2020, Heliyon.

[36]  P. Preux,et al.  Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy , 2019, European Journal of Neurology.

[37]  M. Pugh,et al.  Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. Conflicts. , 2019, Military medicine.

[38]  Kaiyue Zhang,et al.  Population-based study of environmental/occupational lead exposure and amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2019, Neurological Sciences.

[39]  G. Guillemin,et al.  Fungal-contaminated grass and well water and sporadic amyotrophic lateral sclerosis , 2019, Neural regeneration research.

[40]  I. Svanberg,et al.  Mushroom hunting and consumption in twenty-first century post-industrial Sweden , 2019, Journal of Ethnobiology and Ethnomedicine.

[41]  P. Spencer Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC , 2019, Front. Neurol..

[42]  Denis C. Bauer,et al.  Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression , 2019, Scientific Reports.

[43]  J. Raszeja-Wyszomirska,et al.  Acute liver injury, acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculenta. , 2019, Annals of hepatology.

[44]  A. Chiò,et al.  Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study , 2019, Journal of Neurology.

[45]  Luis Carrasco,et al.  Searching for Bacteria in Neural Tissue From Amyotrophic Lateral Sclerosis , 2019, Front. Neurosci..

[46]  W. Camu,et al.  ALS and environment: Clues from spatial clustering? , 2019, Revue neurologique.

[47]  G. Guillemin,et al.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis , 2018, Neurotoxicity Research.

[48]  A. Chiò,et al.  Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches , 2018, Annals of Neurosciences.

[49]  T. H. Nguyen,et al.  Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.

[50]  Jessica a. Cohen,et al.  Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015 , 2018, MMWR. Morbidity and mortality weekly report.

[51]  N. Vanacore,et al.  Amyotrophic Lateral Sclerosis and soccer: an internet survey of 29 Italian players. , 2018, Annali dell'Istituto superiore di sanita.

[52]  P. Spencer Formaldehyde, DNA damage, ALS and related neurodegenerative diseases , 2018, Journal of the Neurological Sciences.

[53]  W. Brandenburg,et al.  Mushroom poisoning epidemiology in the United States , 2018, Mycologia.

[54]  M. Sáez,et al.  Spatial Assessment of the Association between Long-Term Exposure to Environmental Factors and the Occurrence of Amyotrophic Lateral Sclerosis in Catalonia, Spain: A Population-Based Nested Case-Control Study , 2018, Neuroepidemiology.

[55]  A. Chiò,et al.  Spatial epidemiology of amyotrophic lateral sclerosis in Piedmont and Aosta Valley, Italy: a population‐based cluster analysis , 2018, European journal of neurology.

[56]  J. Riancho,et al.  The increasing importance of environmental conditions in amyotrophic lateral sclerosis , 2018, International Journal of Biometeorology.

[57]  K. Srivenugopal,et al.  S-phase Specific Downregulation of Human O6-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21cip1 Proteins in Glioma Cells , 2018, Neoplasia.

[58]  O. Comandini,et al.  Sardinia: Mycovisions from a charming land , 2018 .

[59]  T. Suhara,et al.  A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the disease , 2017, Journal of Clinical Neuroscience.

[60]  P. Nunn 50 years of research on α-amino-β-methylaminopropionic acid (β-methylaminoalanine). , 2017, Phytochemistry.

[61]  Luis Carrasco,et al.  Fungal infection in neural tissue of patients with amyotrophic lateral sclerosis , 2017, Neurobiology of Disease.

[62]  Greg Maguire Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released molecules , 2017, World journal of stem cells.

[63]  Y-H Taguchi,et al.  Genetic Association between Amyotrophic Lateral Sclerosis and Cancer , 2017, Genes.

[64]  A. Chiò,et al.  Occupations and amyotrophic lateral sclerosis: are jobs exposed to the general public at higher risk? , 2017, European journal of public health.

[65]  Marianthi-Anna Kioumourtzoglou,et al.  Occupational formaldehyde and amyotrophic lateral sclerosis , 2017, European Journal of Epidemiology.

[66]  M. Macleod,et al.  Conjugal amyotrophic lateral sclerosis: a case report from Scotland , 2017, BMC Neurology.

[67]  J. Langston,et al.  The MPTP Story , 2017, Journal of Parkinson's disease.

[68]  W. Reid Immunosuppression & Mycotoxins Causing Amyotrophic Lateral Sclerosis , 2017 .

[69]  E. Beghi,et al.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis , 2016, International journal of epidemiology.

[70]  S. Pulst,et al.  Population-based risks for cancer in patients with ALS , 2016, Neurology.

[71]  Stuart Batterman,et al.  Association of Environmental Toxins With Amyotrophic Lateral Sclerosis. , 2016, JAMA neurology.

[72]  M. Klug,et al.  Motor neuron disease mortality rates in U.S. states are associated with well water use , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[73]  N. Wareham,et al.  Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis? , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[74]  M. Zappia,et al.  The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals , 2016, European journal of neurology.

[75]  Angela M. Malek,et al.  The epidemiology of amyotrophic lateral sclerosis. , 2016, Handbook of clinical neurology.

[76]  J. P. Kaiser,et al.  Epigenetic Regulation in Environmental Chemical Carcinogenesis and its Applicability in Human Health Risk Assessment , 2015, International journal of toxicology.

[77]  F. Coppedè,et al.  DNA damage in neurodegenerative diseases. , 2015, Mutation research.

[78]  Luis Carrasco,et al.  Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis , 2015, International journal of biological sciences.

[79]  G. Kisby,et al.  Environmental Neurotoxins Linked to a Prototypical Neurodegenerative Disease , 2015 .

[80]  Z. Janka,et al.  Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive. , 2015, Journal of Alzheimer's disease : JAD.

[81]  J. Little,et al.  A Meta-Analysis of Observational Studies of the Association Between Chronic Occupational Exposure to Lead and Amyotrophic Lateral Sclerosis , 2014, Journal of occupational and environmental medicine.

[82]  M. Druet‐Cabanac,et al.  Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme , 2014, BMJ Open.

[83]  Stephen A. Goutman,et al.  Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan , 2014, PloS one.

[84]  R. Cantello,et al.  A rare case of conjugal amyotrophic lateral sclerosis , 2014, Journal of Neurology.

[85]  H. Seguchi,et al.  Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001–2012 survey results , 2014, BMJ Open.

[86]  E. Beghi Are professional soccer players at higher risk for ALS? , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[87]  L. Pinkerton,et al.  Assessment of ALS mortality in a cohort of formaldehyde-exposed garment workers , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[88]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis and cancer: A register-based study in Sweden , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[89]  E. Stommel,et al.  Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997–2009 , 2013, Muscle & nerve.

[90]  A. Mešić,et al.  Mycophilic or Mycophobic? Legislation and Guidelines on Wild Mushroom Commerce Reveal Different Consumption Behaviour in European Countries , 2013, PloS one.

[91]  J. Sperry,et al.  Natural products containing a nitrogen-nitrogen bond. , 2013, Journal of natural products.

[92]  A. Chiò,et al.  Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[93]  C. Pritchard,et al.  A Case-Study Survey of an Eight-year Cluster of Motor Neurone Disease (MND) Referrals in a Rural English Village: Exploring Possible Aetiological Influences in a Hypothesis Stimulating Study , 2013 .

[94]  Damià Barceló,et al.  Removal of pharmaceuticals, polybrominated flame retardants and UV-filters from sludge by the fungus Trametes versicolor in bioslurry reactor. , 2012, Journal of hazardous materials.

[95]  A. Al-Chalabi,et al.  Young-onset amyotrophic lateral sclerosis: historical and other observations. , 2012, Brain : a journal of neurology.

[96]  R. Fry,et al.  Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? , 2012, Front. Gene..

[97]  K. Kuča,et al.  GYROMITRIN, MUSHROOM TOXIN OF GYROMITRA SPP. , 2012 .

[98]  Rebecca A. B. Burton,et al.  Conjugal Amyotrophic Lateral Sclerosis , 2012, Proceedings.

[99]  Kristina W. Kintziger,et al.  Wild Mushroom Exposures in Florida, 2003–2007 , 2011, Public health reports.

[100]  M. Druet‐Cabanac,et al.  Contribution of geolocalisation to neuroepidemiological studies: Incidence of ALS and environmental factors in Limousin, France , 2011, Journal of the Neurological Sciences.

[101]  G. Kisby,et al.  Is Neurodegenerative Disease a Long-Latency Response to Early-Life Genotoxin Exposure? , 2011, International journal of environmental research and public health.

[102]  L. Samson,et al.  The Cycad Genotoxin MAM Modulates Brain Cellular Pathways Involved in Neurodegenerative Disease and Cancer in a DNA Damage-Linked Manner , 2011, PloS one.

[103]  K. Rothman,et al.  The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study , 2010, Environmental health : a global access science source.

[104]  T. Tango,et al.  Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004 , 2010, Journal of the Neurological Sciences.

[105]  A. Al-Chalabi,et al.  An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[106]  M. Rantalainen,et al.  Structural shifts of gut microbiota as surrogate endpoints for monitoring host health changes induced by carcinogen exposure. , 2010, FEMS microbiology ecology.

[107]  S. Schmidt,et al.  Original Contribution Association Between Blood Lead and the Risk of Amyotrophic Lateral Sclerosis , 2010 .

[108]  M. Vinceti,et al.  Possible involvement of overexposure to environmental selenium in the etiology of amyotrophic lateral sclerosis: a short review. , 2010, Annali dell'Istituto superiore di sanita.

[109]  A. Oliveira,et al.  Conjugal amyotrophic lateral sclerosis in Brazil. , 2009, Arquivos de Neuro-Psiquiatria.

[110]  C. Armon Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.

[111]  M. Thun,et al.  Prospective study of chemical exposures and amyotrophic lateral sclerosis , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[112]  W. Bradley,et al.  Cyanobacteria and BMAA exposure from desert dust: A possible link to sporadic ALS among Gulf War veterans , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[113]  H. Andersson,et al.  Agaritine content of 53 Agaricus species collected from nature , 2009, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[114]  E. Stommel,et al.  A cluster of amyotrophic lateral sclerosis in New Hampshire: A possible role for toxic cyanobacteria blooms , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[115]  A. Chiò,et al.  ALS in Italian professional soccer players: The risk is still present and could be soccer-specific , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[116]  A. Al-Chalabi,et al.  Geographical Clustering of Amyotrophic Lateral Sclerosis in South-East England: A Population Study , 2008, Neuroepidemiology.

[117]  S. Grambow,et al.  Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: Evidence for a Time-Limited Outbreak , 2008, Neuroepidemiology.

[118]  George Turabelidze,et al.  An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. , 2008, Neurotoxicology.

[119]  S. Kuzuhara [ALS-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease). Historical review, epidemiology and concept]. , 2007, Rinsho shinkeigaku = Clinical neurology.

[120]  P. Comba,et al.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data , 2007, European Journal of Epidemiology.

[121]  G. Schellenberg,et al.  Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam , 2007, Neurology.

[122]  F. Venza,et al.  Journal of Ethnobiology and Ethnomedicine Open Access Wild Food Plants of Popular Use in Sicily , 2022 .

[123]  A. M. Leathem,et al.  Poisoning due to raw Gyromitra esculenta (false morels) west of the Rockies. , 2007, CJEM.

[124]  A. Al-Chalabi,et al.  Three soccer playing friends with simultaneous amyotrophic lateral sclerosis , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[125]  M. de Carvalho,et al.  Young‐onset sporadic amyotrophic lateral sclerosis: A distinct nosological entity? , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[126]  David E. Williams,et al.  Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour , 2007, NeuroMolecular Medicine.

[127]  A. Binazzi,et al.  Amyotrophic lateral sclerosis in an Italian professional soccer player. , 2006, Parkinsonism & related disorders.

[128]  S. Woodward,et al.  Wild-gathered fungi for health and rural livelihoods , 2006, Proceedings of the Nutrition Society.

[129]  Mark A Brown Toxicological assessments of Gulf War veterans , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[130]  N. Dessì,et al.  Conjugal amyotrophic lateral sclerosis: a report on a couple from Sardinia, Italy , 1998, The Italian Journal of Neurological Sciences.

[131]  T. Cajthaml,et al.  Structure selectivity in degradation and translocation of polychlorinated biphenyls (Delor 103) with a Pleurotus ostreatus (oyster mushroom) culture. , 2005, Chemosphere.

[132]  Albert C Ludolph,et al.  On the decline and etiology of high‐incidence motor system disease in West Papua (southwest New Guinea) , 2005, Movement disorders : official journal of the Movement Disorder Society.

[133]  E. Granieri,et al.  Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964–1998 , 2005, Journal of Neurology.

[134]  A. Chiò,et al.  Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.

[135]  M. Thun,et al.  Prospective study of military service and mortality from ALS , 2005, Neurology.

[136]  Sohei Yoshida,et al.  Changes in the incidence of amyotrophic lateral sclerosis in Wakayama, Japan , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[137]  R. Mai,et al.  Conjugal amyotrophic lateral sclerosis: toxic clustering or chance? , 1997, The Italian Journal of Neurological Sciences.

[138]  K. Teschke,et al.  Occupational exposure to chemical agents in the paper industry , 2004, International archives of occupational and environmental health.

[139]  J. Mendell,et al.  Three cases of amyotrophic lateral sclerosis in a common occupational environment , 1987, Journal of Neurology.

[140]  L. Wilkins,et al.  Occurrence of amyotrophic lateral sclerosis among Gulf War veterans , 2003, Neurology.

[141]  R. Haley Excess incidence of ALS in young Gulf War veterans , 2003, Neurology.

[142]  A C Gatrell,et al.  Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. , 2003, American journal of epidemiology.

[143]  P. Corcia,et al.  A clustering of conjugal amyotrophic lateral sclerosis in southeastern France. , 2003, Archives of neurology.

[144]  D. Galasko,et al.  Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. , 2003, American journal of epidemiology.

[145]  A. Malaspina,et al.  Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy. , 2002, Functional neurology.

[146]  David M. Umbach,et al.  Lead Exposure and Amyotrophic Lateral Sclerosis , 2002, Epidemiology.

[147]  A. Chiò,et al.  Conjugal amyotrophic lateral sclerosis: suggestion for the implication of environmental factors , 2001, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[148]  E. Gogolashvili,et al.  Detoxication of hydrazine in waste waters , 2001 .

[149]  J. Hugon,et al.  Damage and repair of nerve cell DNA in toxic stress. , 1999, Drug metabolism reviews.

[150]  Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 17-24 February 1998. , 1999, IARC monographs on the evaluation of carcinogenic risks to humans.

[151]  R. B. Davies,et al.  Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria , 1998, Journal of neurology, neurosurgery, and psychiatry.

[152]  T. Kihira,et al.  Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989–1993: Active or disappearing focus? , 1998, Journal of the Neurological Sciences.

[153]  T. Nomiyama,et al.  Evidence on N-acetyltransferase allele-associated metabolism of hydrazine in Japanese workers. , 1998, Journal of occupational and environmental medicine.

[154]  C. Hawkes,et al.  British motor neuron disease twin study. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[155]  G. Román,et al.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[156]  R. Orrell,et al.  Patterns of inheritance in United Kingdom families with amyotrophic lateral sclerosis. , 1996 .

[157]  J. De Pedro-Cuesta,et al.  An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. , 1996, Neuroepidemiology.

[158]  K. M. Chen,et al.  [Disappearance of ALS from Guam: implications for exogenous causes]. , 1995, Rinsho shinkeigaku = Clinical neurology.

[159]  N. Saravanan,et al.  Bis-hydrazine metal maleates and fumarates: Preparation, spectral and thermal studies , 1995, Proceedings / Indian Academy of Sciences.

[160]  G. Kisby,et al.  Cycad toxin-induced damage of rodent and human pancreatic β-cells , 1995 .

[161]  B. Tóth,et al.  Gyromitra esculenta mushroom: a comparative assessment of its carcinogenic potency. , 1994, In vivo.

[162]  R. C. Shank,et al.  Hydralazine and other hydrazine derivatives and the formation of DNA adducts. , 1994, Toxicology and applied pharmacology.

[163]  M. Billiard,et al.  Conjugal amyotrophic lateral sclerosis , 1994, Neurology.

[164]  L. Morrison,et al.  Conjugal amyotrophic lateral sclerosis , 1993, Neurology.

[165]  J. Slattery,et al.  Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[166]  J. S. Gecan,et al.  Toxic Mushroom Contamination of Wild Mushrooms in Commercial Distribution. , 1993, Journal of food protection.

[167]  M. Giagheddu,et al.  Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study , 1993, Acta neurologica Scandinavica.

[168]  L. C. Leite,et al.  Carbon-centered free radical formation during the metabolism of hydrazine derivatives by neutrophils. , 1993, Biochemical pharmacology.

[169]  Deanna D. Belli,et al.  Pathologic findings in the retinal pigment epitheliopathy associated with the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. , 1993, Ophthalmology.

[170]  B. Tóth Teratogenic hydrazines: a review. , 1993, In vivo.

[171]  A. Chiò,et al.  Risk factors in motor neuron disease: a case-control study. , 1991, Neuroepidemiology.

[172]  B. Tóth,et al.  Poisoning by Gyromitra esculenta–a review , 1991, Journal of applied toxicology : JAT.

[173]  A. Ludolph,et al.  Slow toxins, biologic markers, and long‐latency neurodegenerative disease in the western Pacific region , 1991, Neurology.

[174]  B. Tóth Carcinogenic fungal hydrazines. , 1991, In vivo.

[175]  D. Vassilopoulos,et al.  Amyotrophic lateral sclerosis in southern Greece: an epidemiologic study. , 1991, Neuroepidemiology.

[176]  A. Gatrell,et al.  Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986. A geographical study. , 1990, Archives of neurology.

[177]  J. Taylor,et al.  Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. , 1990, Archives of neurology.

[178]  C. Hawkes,et al.  MOTONEURON DISEASE: A DISORDER SECONDARY TO SOLVENT EXPOSURE? , 1989, The Lancet.

[179]  K. Radhakrishnan,et al.  Conjugal motor neurone disease. , 1987, The Journal of the Association of Physicians of India.

[180]  M. Carreras,et al.  Risk factors for amyotrophic lateral sclerosis in Sardinia, Italy , 1989 .

[181]  J. P. Davis,et al.  Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. , 1989, Journal of clinical epidemiology.

[182]  A. Iannone,et al.  Free radical activation of monomethyl and dimethyl hydrazines in isolated hepatocytes and liver microsomes. , 1989, Free radical biology & medicine.

[183]  M. Carreras,et al.  Motor neuron disease in the province of Ferrara, Italy, in 1964–1982 , 1988, Neurology.

[184]  P. Khanna,et al.  Nitrosamine in leather dust extracts. , 1988, British journal of industrial medicine.

[185]  V. Palmer,et al.  CYCAD USE AND MOTOR NEURONE DISEASE IN KII PENINSULA OF JAPAN , 1987, The Lancet.

[186]  V. Palmer,et al.  CYCAD USE AND MOTOR NEURONE DISEASE IN IRIAN JAYA , 1987, The Lancet.

[187]  J. Mitchell,et al.  Motor neurone disease in the Lothian Region of Scotland 1961-81. , 1986, Journal of epidemiology and community health.

[188]  K. Tadera,et al.  Hepatic and spinal lesions in goats chronically intoxicated with cycasin. , 1986, Nihon juigaku zasshi. The Japanese journal of veterinary science.

[189]  M. Martínez Ferri,et al.  [Conjugal amyotrophic lateral sclerosis]. , 1986, Neurologia.

[190]  Y. Herishanu,et al.  Motor neuron disease in textile factory workers , 1985, Israel journal of medical sciences.

[191]  W. Bradley,et al.  Amyotrophic leteral sclerosis: Part 2. Etiopathogenesis , 1985 .

[192]  C. Andary,et al.  Variations of monomethylhydrazine content in Gyromitra esculenta. , 1985 .

[193]  R. Garruto,et al.  Disappearance of high‐incidence amyotrophic lateral sclerosis and parkinsonism‐dementia on Guam , 1985, Neurology.

[194]  E. Granieri,et al.  Reply , 1984 .

[195]  M. Giagheddu,et al.  Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy , 1983, Acta neurologica Scandinavica.

[196]  L. Pickle,et al.  Geographic distribution of motor neuron disease and correlation with possible etiologic factors , 1983, Neurology.

[197]  C. Warlow,et al.  Motor neuron disease in England and Wales, 1959-1979. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[198]  C. Melmed,et al.  A cluster of amyotrophic lateral sclerosis. , 1982, Archives of neurology.

[199]  T. Munsat,et al.  Conjugal motor neuron disease , 1982, Neurology.

[200]  A. Salazar,et al.  Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea , 1982, Neurology.

[201]  R. Garruto,et al.  Amyotrophic lateral sclerosis and parkinsonism‐dementia among Filipino migrants to Guam , 1981, Annals of neurology.

[202]  M. G. Macnaughton,et al.  Effects of hydrazine on the activated sludge process , 1981 .

[203]  S. De Flora,et al.  DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. , 1981, Cancer research.

[204]  C. Hawkes,et al.  MOTOR NEURONE DISEASE IN LEATHER WORKERS , 1981, The Lancet.

[205]  R. Garruto,et al.  Amyotrophic lateral sclerosis among chamorro migrants from guam , 1980, Annals of neurology.

[206]  M. Sanders Clustering of amyotrophic lateral sclerosis. , 1980, JAMA.

[207]  R. Adamson,et al.  Carcinogenicity and hepatotoxicity of cycasin and its aglycone methylazoxymethanol acetate in nonhuman primates. , 1980, Journal of the National Cancer Institute.

[208]  T. Winter,et al.  Chemical oxygen scavengers: use of hydrazine and tannins for boiler water treatment , 1978 .

[209]  Morris Pollard,et al.  Induction of colon tumors in 1,2-dimethylhydrazine-resistant Lobund Wistar rats by methylazoxymethanol acetate. , 1978, Journal of the National Cancer Institute.

[210]  B. Tóth,et al.  Formation of methylhydrazine from acetaldehyde N-methyl-N-formylhydrazone, a component of Gyromitra esculenta. , 1977, Cancer research.

[211]  A. W. Kilness,et al.  Amyotrophic lateral sclerosis in a high selenium environment. , 1977, JAMA.

[212]  H. Pyysalo Tests for gyro mitrin, a poisonous compound in false morel gyromitra esculenta , 1976, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.

[213]  B. Ames,et al.  Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[214]  J. Brody,et al.  Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. I. Descriptive epidemiology. , 1975, American journal of epidemiology.

[215]  J. Brody,et al.  Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. II. Familial and genetic studies. , 1975, American journal of epidemiology.

[216]  F. Hochberg,et al.  CLUSTERING OF AMYOTROPHIC LATERAL SCLEROSIS , 1974 .

[217]  F. H. Shillito,et al.  Pyridoxine and phenobarbital as treatment for aerozine-50 toxicity. , 1970, Aerospace medicine.

[218]  H. Matsumoto,et al.  Studies on Methylazoxymethanol , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[219]  L. Kurland,et al.  Amyotrophic lateral sclerosis-Parkinsonism dementia complex of Guam: further genetic investigations. , 1969, American journal of human genetics.

[220]  R. C. Shank,et al.  Similarities between the biochemical actions of cycasin and dimethylnitrosamine. , 1967, The Biochemical journal.

[221]  P. List,et al.  Gyromitrin, das gift der fruehjahrslorchel, gyromitra (helvella) esculenta fr.☆ , 1967 .

[222]  H. Matsumoto,et al.  Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro. , 1966, The Biochemical journal.

[223]  H. Matsumoto,et al.  STUDIES ON METHYLAZOXYMETHANOL, THE AGLYCONE OF CYCASIN. ISOLATION, BIOLOGICAL, AND CHEMICAL PROPERTIES. , 1965, Archives of biochemistry and biophysics.

[224]  D. Dastur CYCAD TOXICITY IN MONKEYS: CLINICAL, PATHOLOGICAL, AND BIOCHEMICAL ASPECTS. , 1964, Federation proceedings.

[225]  A. Veis,et al.  The action of hydrazine on collagen. I. Chemical modification. , 1963, The Journal of biological chemistry.

[226]  D. L. Schoene,et al.  Maleic Hydrazide, a Unique Growth Regulant. , 1949, Science.